- Home
- Publications
- Publication Search
- Publication Details
Title
Reassessing B cell contributions in multiple sclerosis
Authors
Keywords
-
Journal
NATURE IMMUNOLOGY
Volume 19, Issue 7, Pages 696-707
Publisher
Springer Nature
Online
2018-06-14
DOI
10.1038/s41590-018-0135-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity
- (2018) Haijing Wu et al. Cellular & Molecular Immunology
- Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis
- (2018) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
- (2018) Martin Diebold et al. JOURNAL OF AUTOIMMUNITY
- Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
- (2018) Hanane Touil et al. Journal of Neuroinflammation
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
- (2018) Simon Glatigny et al. Cold Spring Harbor Perspectives in Medicine
- Effector T Cells in Multiple Sclerosis
- (2018) Belinda J. Kaskow et al. Cold Spring Harbor Perspectives in Medicine
- Clinical Course of Multiple Sclerosis
- (2018) Sylvia Klineova et al. Cold Spring Harbor Perspectives in Medicine
- Regulatory T Cells: From Discovery to Autoimmunity
- (2018) Alexandra Kitz et al. Cold Spring Harbor Perspectives in Medicine
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Bruton’s Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus
- (2018) Anne B. Satterthwaite Frontiers in Immunology
- Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
- (2017) Rui Li et al. JOURNAL OF IMMUNOLOGY
- Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
- (2017) Qi Wu et al. JOURNAL OF IMMUNOLOGY
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
- (2017) Vinzenz Fleischer et al. Multiple Sclerosis Journal
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
- (2017) Sergio E. Baranzini et al. TRENDS IN GENETICS
- Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI
- (2017) Martina Absinta et al. eLife
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
- (2017) Vinzenz Fleischer et al. Multiple Sclerosis Journal
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Dimethyl fumarate alters B-cell memory and cytokine production in MS patients
- (2017) Matthew D. Smith et al. Annals of Clinical and Translational Neurology
- Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
- (2017) David Baker et al. EBioMedicine
- Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
- (2016) Fabiana Rizzo et al. IMMUNOLOGY AND CELL BIOLOGY
- Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
- (2016) Shiri Blumenfeld et al. JOURNAL OF AUTOIMMUNITY
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
- (2016) Rui Li et al. JOURNAL OF IMMUNOLOGY
- The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
- (2016) Simone M. Brändle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies in multiple sclerosis oligoclonal bands target debris
- (2016) Ryan C. Winger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients
- (2016) Giuseppe Mameli et al. PLoS One
- B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
- (2016) Kristbjörg Bjarnadóttir et al. Scientific Reports
- Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells
- (2015) Bettina Trinschek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis
- (2015) Tessa Dhaeze et al. JOURNAL OF IMMUNOLOGY
- Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation
- (2015) Maria Antonietta Mazzola et al. Journal of Neuroinflammation
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Effects of dimethyl fumarate on lymphocyte subsets
- (2015) Regina Berkovich et al. Multiple Sclerosis and Related Disorders
- The Ins and Outs of B Cells in Multiple Sclerosis
- (2015) Kevin Blauth et al. Frontiers in Immunology
- B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
- (2015) Laure Michel et al. Frontiers in Immunology
- Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis
- (2014) Luisa M. Villar et al. ANNALS OF NEUROLOGY
- Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity
- (2014) Ingo Hilgendorf et al. CIRCULATION
- Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
- (2014) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
- (2014) Masanori Matsumoto et al. IMMUNITY
- B cells mediate chronic allograft rejection independently of antibody production
- (2014) Qiang Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis
- (2014) Georg F. Weber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
- (2014) V. Lampropoulou et al. JOURNAL OF IMMUNOLOGY
- A Role for Intrathymic B Cells in the Generation of Natural Regulatory T Cells
- (2014) S. N. Walters et al. JOURNAL OF IMMUNOLOGY
- BAFF Suppresses IL-15 Expression in B Cells
- (2014) N. Ma et al. JOURNAL OF IMMUNOLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- B Cell Antigen Presentation in the Initiation of Follicular Helper T Cell and Germinal Center Differentiation
- (2014) L. G. Barnett et al. JOURNAL OF IMMUNOLOGY
- Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
- (2014) Valeria Studer et al. JOURNAL OF NEUROIMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
- (2014) Adipong Brickshawana et al. LANCET NEUROLOGY
- Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis
- (2014) Elodie Nerrant et al. Multiple Sclerosis Journal
- Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
- (2014) Clemens Warnke et al. Multiple Sclerosis Journal
- Differential effects of fingolimod on B-cell populations in multiple sclerosis
- (2014) Masakazu Nakamura et al. Multiple Sclerosis Journal
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype
- (2014) Griselda V Zuccarino-Catania et al. NATURE IMMUNOLOGY
- Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production
- (2014) Elizabeth C Rosser et al. NATURE MEDICINE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease
- (2014) V. Kraus et al. NEUROLOGY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Yusei Miyazaki et al. PLoS One
- Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
- (2014) Nathalie Muls et al. PLoS One
- Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
- (2014) Nele Claes et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- Readout of Epigenetic Modifications
- (2013) Dinshaw J. Patel et al. Annual Review of Biochemistry
- Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
- (2013) J. Sellner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis
- (2013) Chris L. Ayers et al. CLINICAL IMMUNOLOGY
- Specific peripheral B cell tolerance defects in patients with multiple sclerosis
- (2013) Tuure Kinnunen et al. JOURNAL OF CLINICAL INVESTIGATION
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis
- (2013) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
- (2013) Laura D. Serpero et al. Journal of Neuroimmune Pharmacology
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Activated microglia enhance neurogenesis via trypsinogen secretion
- (2013) A. M. Nikolakopoulou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation
- (2013) J. L. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B Cell Repopulation After Alemtuzumab Induction-Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B Cells
- (2012) S. Heidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases
- (2012) Eric Meffre Annals of the New York Academy of Sciences
- Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells
- (2012) T. Kinnunen et al. BLOOD
- Altered microRNA expression in B lymphocytes in multiple sclerosis
- (2012) Claudia Sievers et al. CLINICAL IMMUNOLOGY
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Novel IL-10-Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
- (2012) A. Ray et al. JOURNAL OF IMMUNOLOGY
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Animal models of multiple sclerosis: the good, the bad and the bottom line
- (2012) Richard M Ransohoff NATURE NEUROSCIENCE
- B cells and antibodies in multiple sclerosis pathogenesis and therapy
- (2012) Markus Krumbholz et al. Nature Reviews Neurology
- Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
- (2012) P. J. Waters et al. NEUROLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients
- (2012) Refik Pul et al. PLoS One
- Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
- (2012) Lars Börnsen et al. PLoS One
- Innate Response Activator B Cells Protect Against Microbial Sepsis
- (2012) P. J. Rauch et al. SCIENCE
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
- (2011) Grant A Hill-Cawthorne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut
- (2011) Jörg H. Fritz et al. NATURE
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
- (2009) A. Vogelgesang et al. ACTA NEUROLOGICA SCANDINAVICA
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Depletion of functionally active CD20+ T cells by rituximab treatment
- (2009) Esther Wilk et al. ARTHRITIS AND RHEUMATISM
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce “oligoclonal bands”
- (2009) Hans-Christian von Büdingen et al. JOURNAL OF NEUROIMMUNOLOGY
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1 in human monocytes and multiple sclerosis
- (2009) D. Burger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Helminth infections associated with multiple sclerosis induce regulatory B cells
- (2008) Jorge Correale et al. ANNALS OF NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Interferon Beta–Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells
- (2008) Mirjam Korporal et al. ARCHIVES OF NEUROLOGY
- Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis
- (2008) Manuel Comabella et al. CLINICAL IMMUNOLOGY
- Mitoxantrone Does Not Restore the Impaired Suppressive Function of Natural Regulatory T Cells in Patients Suffering from Multiple Sclerosis
- (2008) Norman Putzki et al. EUROPEAN NEUROLOGY
- Sites and Stages of Autoreactive B Cell Activation and Regulation
- (2008) Mark J. Shlomchik IMMUNITY
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started